Skip to main content
Skip to footer
Sildenafil Drug Interactions & Contra-indications — 2025 Safety Checklist
Sildenafil: Quick Interaction Grid (2025)
Category |
Examples |
Action |
Absolute CI |
Nitrates, Riociguat |
Contra-indicated |
Strong CYP3A4 inhib. |
Ritonavir, Ketoconazole |
Start 25 mg; max 25/48 h |
α-Blockers |
Tamsulosin, Doxazosin |
Separate ≥ 4 h |
Inducers |
Rifampin, Bosentan |
Consider 150–200 mg |
Additive BP Drop |
Amlodipine, Alcohol ↑ |
Monitor BP |
Absolute Contra-indications
- Nitrates (e.g., nitroglycerin, isosorbide): Severe hypotension risk. Never combine.
- Riociguat: Soluble guanylate cyclase stimulator. Profound BP drop./li>
- Recent MI or stroke (<6 months): Cardiac instability. Avoid use. [PubMed]
- Severe hypotension (<90/50 mmHg): Baseline low BP. Contra-indicated.
- Known hypersensitivity: Allergy to sildenafil or excipients.
Major Caution & Dose-Adjust – CYP3A4 Inhibitors
- Ritonavir, indinavir: Potent CYP3A4 inhibitors. Max 25 mg/48h. [PubMed]
- Ketoconazole, itraconazole: Strong inhibitors. Start low, titrate carefully.
- Erythromycin, clarithromycin: Moderate inhibitors. Monitor for side effects.
- Grapefruit juice: May increase sildenafil levels. Limit intake.
- Saquinavir, atazanavir: HIV protease inhibitors. Use lowest dose possible.
Additive Hypotension – α-blockers, Alcohol, Antihypertensives
- α-Blockers (tamsulosin, doxazosin): Separate doses by ≥4 hours to reduce syncope risk.
- Alcohol (excess): Increases vasodilation, may cause dizziness/fainting.
- Amlodipine, other CCBs: Additive BP lowering. Monitor closely.
- ACE inhibitors, ARBs: Cumulative hypotensive effect possible.
- Diuretics: May potentiate BP drop, especially in elderly.
Special Populations
- Severe renal impairment (CrCl <30 ml/min): Start at 25 mg; titrate with caution.
- Severe hepatic impairment: Use lowest dose; monitor for adverse effects.
- Retinitis pigmentosa: Rare hereditary eye disease; avoid use (risk of vision loss).
- Age >65 years: Increased sensitivity; consider lower starting dose.
- Bleeding disorders: Use with caution; theoretical risk of epistaxis/bleeding.